ArticleFrontiers in oncology2023

PARP inhibitors in the treatment of ARID1A mutant ovarian clear cell cancer: PI3K/Akt1-dependent mechanism of synthetic lethality.

Vasily A Yakovlev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.